Our Phone Systems are Down
Please contact us the following ways:
- Use PATIENT PORTAL to send a message to your provider
- Click on SCHEDULE APPOINTMENT if you need to be seen.
If you are experiencing difficulty urinating, a weak urine stream, blood in the urine, or other urinary symptoms, you may be affected by urethral stricture disease. Left untreated, urethral strictures can lead to recurring infections, bladder problems, and other serious complications.
Discover the symptoms, causes, and treatment options available, including the minimally invasive Optilume® procedure.
Urethral stricture disease occurs when there is an obstruction in the urethra that prevents the flow of urine and emptying of the bladder properly. The stricture will block the narrow passage of the urethra, making it difficult and painful to urinate. Urethral strictures are often caused by traumatic, inflammatory or ischemic processes that can lead to severe problems if left untreated.
Letting these issues go on too long without seeking medical treatment can cause kidney damage, urinary tract infections and general discomfort or pain with urination.
Numerous medical and traumatic complications can lead to urethral stricture, yet 30% of the causes[1] of this condition are unknown. Here are the most common factors that lead to this issue.
Sexually transmitted infections (STIs), such as chlamydia and gonorrhea, are among the most common causes of swelling and scarring in the urethra, creating urethral strictures.
Some skin conditions, such as Lichen sclerosis, create thin, white patches of skin in the genital area and lead to chronic inflammation, itching and bruising. Urinary tract infections (UTIs) can also create urethral strictures.
Some people are born with improperly formed or irregular urinary structures and genitals. One example of this is Hypospadias, which is a congenital disorder where the opening of the urethra is located on the underside of the penis instead of the tip. Adults who were born with this condition will likely have more urethral strictures.
Injury or trauma to the genital and pelvic area can cause strictures, such as falling, damage from surgical tools or being hit in the genitals.
Urethral or prostate cancer can create many complications, such as scarring or an enlarged prostate, in the urethra, leading to strictures. Radiation therapy treatment used to kill cancer cells in this region can also cause urethral strictures. Just over 2% of prostate cancer patients[2] can experience radiation-related urethral strictures.
There are several ways for doctors to determine whether you have a urethral stricture, such as by conducting a physical exam or using ultrasound and X-rays to produce images of the urethra to locate the blockage. Doctors can also use a urinalysis (UA), urine culture or urethral culture to determine if you have a urethral stricture. Imaging and endoscopic examinations are often necessary to determine the cause of this condition.
Two other common procedures for urethral strictures are:
During this in-office procedure, a urologist inserts a small, lubricated urethroscope into the urethra. The scope contains a tiny camera that allows the doctor to view the inside of the urethra, identify areas of narrowing, and evaluate the structure and function of the urethral sphincter.
A flexible cystoscope may also be used to inspect the bladder for any abnormalities. The information gathered during the procedure helps the doctor determine the most appropriate treatment plan.
Some skin conditions, such as Lichen sclerosis, create thin, white patches of skin in the genital area and lead to chronic inflammation, itching and bruising. Urinary tract infections (UTIs) can also create urethral strictures.
A retrograde urethrogram is a specialized outpatient X-ray procedure used to evaluate urethral strictures in greater detail. During the test, a contrast dye is gently introduced into the urethra, allowing your doctor to view the entire urethra on X-ray images. This helps determine the location, length, severity, and number of strictures that may be present.
The detailed images produced during a retrograde urethrogram are important for diagnosing urethral strictures and planning the most effective treatment. In more complex cases, the test may be combined with additional imaging to better define the stricture and help surgeons prepare for a reconstructive procedure. It can also be used to evaluate urethral injuries caused by trauma and monitor healing after treatment.
Urethral strictures are far more common in men than women because the male urethra is longer and more susceptible to injury, infection, and scarring. While women and children can develop strictures, they are much less common. People who experience recurrent urinary tract infections (UTIs), urethritis, or other chronic urinary conditions may also have an increased risk.
In the United States, urethral strictures account for more than 5,000 hospital admissions and 1.5 million healthcare visits among men each year. The condition is most common in adults over age 65.
People suffering from urethral strictures often need to undergo one or more treatment options, which can be surgical or minimally invasive, to avoid a worse issue. Urinary or testicular infections could develop, such as kidney stones, if left untreated. Likewise, excessive urinary retention can cause an enlarged bladder and other kidney problems.
Intermittent self-catheterization (ISC) allows patients with urethral strictures to empty their bladder by periodically inserting a thin catheter through the urethra. While ISC can help keep the urethra open and improve urine flow, it can be inconvenient and uncomfortable for some patients. Frequent catheter use may also increase the risk of infection, irritation, scarring, or urinary tract complications.
Optilume is the world’s first Drug Coated Balloon approved by the FDA to treat patients with Urethral Strictures. The Optilume Urethral Drug Coated Balloon technology simultaneously dilates and delivers an anti-proliferative medicine to the urethral stricture.
During the Optilume procedure, The Optilume device expands the scar tissue surrounding the urethral stricture creating a dilation and micro-fissures across the affected area. This allows the drug, paclitaxel, to be delivered directly to the stricture. This combined technique results in limiting scar tissue generation and helps prevent future stricture recurrence.
Optilume® is proven to provide superior results compared to the standard of care for endoscopic management. The ROBUST III Randomized Controlled Clinical Trial showed that 83% of patients remained free from re-treatments for their urethral stricture 1 year after their Optilume procedure.[3]
Please contact us the following ways: